Skip to content

Drug interactions

Dacomitinib + Propafenone

Severity: Major

Dacomitinib and Propafenone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dacomitinib is a strong inhibitor of CYP2D6, the main enzyme that converts propafenone to its 5-hydroxy metabolite. Propafenone concentrations may rise substantially, increasing the risk of proarrhythmia, conduction disturbances and CNS or other dose-related adverse effects.

What this interaction means in plain words

Dacomitinib and Propafenone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Dacomitinib belongs to Oncology; Propafenone belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Dacomitinib inhibits CYP2D6, reducing propafenone clearance.

What to do

Avoid the combination where possible and consider an alternative antiarrhythmic. If it cannot be avoided, use a reduced propafenone dose with ECG monitoring for PR/QRS widening and arrhythmia.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dacomitinib and Propafenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dacomitinib with Propafenone?

MediHelp rates the interaction as major. Dacomitinib and Propafenone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Dacomitinib is a strong inhibitor of CYP2D6, the main enzyme that converts propafenone to its 5-hydroxy metabolite. Propafenone concentrations may rise substantially, increasing the risk of proarrhythmia, conduction disturbances and CNS or other dose-related adverse effects.

How serious is the interaction between Dacomitinib and Propafenone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible and consider an alternative antiarrhythmic. If it cannot be avoided, use a reduced propafenone dose with ECG monitoring for PR/QRS widening and arrhythmia.

What other medicines interact with Propafenone?

MediHelp also lists interactions of Propafenone with, for example, Dofetilide, Dronedarone, Nilotinib. The full list is on the Propafenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in